TA
ALXN

Teton Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Teton Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-24,089
Closed -$2.95M – 466
2016
Q3 		$2.95M Hold
24,089
– – 0.26% 133
2016
Q2 		$2.81M Buy
24,089
+2,713
+13% +$385K 0.25% 127
2016
Q1 		$2.98M Sell
21,376
-12
-0.1% -$1.76K 0.28% 122
2015
Q4 		$4.08M Sell
21,388
-20,046
-48% -$3.5M 0.36% 79
2015
Q3 		$6.48M Sell
41,434
-4,364
-10% -$796K 0.49% 46
2015
Q2 		$8.28M Buy
45,798
+6,888
+18% +$1.19M 0.57% 30
2015
Q1 		$6.74M Sell
38,910
-20,126
-34% -$3.64M 0.46% 56
2014
Q4 		$10.9M Sell
59,036
-8,762
-13% -$1.62M 0.71% 20
2014
Q3 		$11.2M Buy
67,798
+131
+0.2% +$21.5K 0.8% 11
2014
Q2 		$10.6M Sell
67,667
-3,631
-5% -$573K 0.7% 21
2014
Q1 		$10.8M Sell
71,298
-7,081
-9% -$1.13M 0.73% 16
2013
Q4 		$10.4M Buy
78,379
+39
+0% +$4.68K 0.73% 14
2013
Q3 		$9.1M Buy
78,340
+80
+0.1% +$8.78K 0.7% 21
2013
Q2 		$7.22M Buy
+78,260
New +$7.54M 0.63% 33

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Teton Advisors's ALXN Position: Q4 2016 in Review

Teton Advisors sold out of Alexion Pharmaceuticals (ALXN) in Q4 2016, closing a stake of 24,089 shares — an estimated $2.95M sold.

Teton Advisors first reported a position in ALXN in Q2 2013 and held it in 14 quarters. The position peaked at $11.2M in Q3 2014. 548 funds tracked by Wall St. Rank hold ALXN as of Q4 2016.

  • Teton Advisors reported no remaining Alexion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Teton Advisors sold 24,089 Alexion Pharmaceuticals shares in Q4 2016, an estimated $2.95M.
  • Teton Advisors first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Teton Advisors's Alexion Pharmaceuticals position peaked at $11.2M in Q3 2014.
  • 548 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2016.

Based on Teton Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.